祥生医疗 (688358.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.6x

Market Cap

CNY 3.14B

MomentumView details →

1D Return

−3.31%

YTD Return

—

RSI (14)

45.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.6x

Market Cap

CNY 3.14B

RSI (14)

45.3

MomentumView details →

1D Return

−3.31%

YTD Return

—

ProfitabilityView details →

Gross Margin

59.00%

Net Margin

27.77%

EBITDA Margin

31.78%

ROE (TTM)

8.52%

ROA (TTM)

7.68%

Asset Turnover

0.27x

GrowthView details →

Revenue YoY

−4.48%

EPS YoY

−11.74%

FCF YoY

−57.37%

Revenue CAGR 3Y

+4.60%

EPS CAGR 3Y

+3.43%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.21

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

10.20x

Quick Ratio

9.18x

Div Yield

3.12%

Div Rate

CNY 0.88

Div Growth 1Y

−12.00%

Financials snapshotView financials →

Revenue (TTM)

435.38M

Net Income (TTM)

120.91M

Op. CF (TTM)

69.23M

Latest newsMore news →

Xiangsheng Medical announced its first-half 2026 results: net profit attributable to shareholders was 68.9576 million yuan, down 1.06% year-on-year.8d ago

Xiangsheng Medical proposed a cash dividend of 3.5 yuan per 10 shares (tax inclusive), totaling 39.244 million yuan (tax inclusive).8d ago

Similar companies

Jenscare Scientific Co., Ltd.09877.HK Ekso Bionics Holdings, Inc. Common StockCHRN 健麾信息605186.SH 安旭生物688075.SH 东方生物688298.SH 科美诊断688468.SH Find similar companies →

Latest newsMore news →

Xiangsheng Medical announced its first-half 2026 results: net profit attributable to shareholders was 68.9576 million yuan, down 1.06% year-on-year.8d ago Xiangsheng Medical proposed a cash dividend of 3.5 yuan per 10 shares (tax inclusive), totaling 39.244 million yuan (tax inclusive).8d ago